Annual CFF
$315.39 M
+$147.07 M+87.38%
31 December 2023
Summary:
Apogee Therapeutics annual cash flow from financing activities is currently $315.39 million, with the most recent change of +$147.07 million (+87.38%) on 31 December 2023. APGE annual CFF is now at all-time high.APGE Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$383.00 K
+$533.00 K+355.33%
30 September 2024
Summary:
Apogee Therapeutics quarterly cash flow from financing activities is currently $383.00 thousand, with the most recent change of +$533.00 thousand (+355.33%) on 30 September 2024. Over the past year, it has dropped by -$316.92 million (-99.88%). APGE quarterly CFF is now -99.91% below its all-time high of $450.52 million, reached on 31 March 2024.APGE Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$450.54 M
-$316.92 M-41.29%
30 September 2024
Summary:
Apogee Therapeutics TTM cash flow from financing activities is currently $450.54 million, with the most recent change of -$316.92 million (-41.29%) on 30 September 2024. Over the past year, it has increased by +$134.94 million (+42.75%). APGE TTM CFF is now -41.29% below its all-time high of $767.46 million, reached on 30 June 2024.APGE TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
APGE Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +87.4% | -99.9% | +42.8% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
APGE Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +87.4% | -99.9% | +122.6% | -41.3% | >+9999.0% |
| 5 y | 5 years | at high | +87.4% | -99.9% | +122.6% | -41.3% | >+9999.0% |
| alltime | all time | at high | +87.4% | -99.9% | +122.6% | -41.3% | >+9999.0% |
Apogee Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $383.00 K(-355.3%) | $450.54 M(-41.3%) |
| June 2024 | - | -$150.00 K(-100.0%) | $767.46 M(+0.2%) |
| Mar 2024 | - | $450.52 M(<-9900.0%) | $765.91 M(+142.8%) |
| Dec 2023 | $315.39 M | -$213.00 K(-100.1%) | $315.39 M(-0.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | $317.30 M(<-9900.0%) | $315.60 M(<-9900.0%) |
| June 2023 | - | -$1.69 M(<-9900.0%) | -$1.69 M(<-9900.0%) |
| Mar 2023 | - | $0.00 | $0.00 |
| Dec 2022 | $168.32 M | - | - |
FAQ
- What is Apogee Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Apogee Therapeutics?
- What is Apogee Therapeutics annual CFF year-on-year change?
- What is Apogee Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Apogee Therapeutics?
- What is Apogee Therapeutics quarterly CFF year-on-year change?
- What is Apogee Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Apogee Therapeutics?
- What is Apogee Therapeutics TTM CFF year-on-year change?
What is Apogee Therapeutics annual cash flow from financing activities?
The current annual CFF of APGE is $315.39 M
What is the all time high annual CFF for Apogee Therapeutics?
Apogee Therapeutics all-time high annual cash flow from financing activities is $315.39 M
What is Apogee Therapeutics annual CFF year-on-year change?
Over the past year, APGE annual cash flow from financing activities has changed by +$147.07 M (+87.38%)
What is Apogee Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of APGE is $383.00 K
What is the all time high quarterly CFF for Apogee Therapeutics?
Apogee Therapeutics all-time high quarterly cash flow from financing activities is $450.52 M
What is Apogee Therapeutics quarterly CFF year-on-year change?
Over the past year, APGE quarterly cash flow from financing activities has changed by -$316.92 M (-99.88%)
What is Apogee Therapeutics TTM cash flow from financing activities?
The current TTM CFF of APGE is $450.54 M
What is the all time high TTM CFF for Apogee Therapeutics?
Apogee Therapeutics all-time high TTM cash flow from financing activities is $767.46 M
What is Apogee Therapeutics TTM CFF year-on-year change?
Over the past year, APGE TTM cash flow from financing activities has changed by +$134.94 M (+42.75%)